Strategic Navigation for Clinical Trials in Mid-Size Biopharma—Insights from an Executive Director’s Perspective

About this session

Session: MASTERING PROVIDER SELECTION & VENDOR OVERSIGHT

All Pharma Industries are facing challenges when conducting clinical trials, and even more when the trials are complex. How is a mid-size pharma approaching the issues? Indeed complex studies need to be properly designed, and especially when the resources are limited and there is a high competitiveness in the investigational field. Study failure in a mid-size pharma is impacting in a material way the sustainability of the company, we need to ensure this risk is being minimized and carefully controlled in all areas. Involving all players in study design and feasibility is key to success.

Speaker

• EA

  Estrella A Garcia Alvarez

  Dir Global Clinical Operations · Almirall SA

  Speaker